Diabetes patients have a higher risk in morbidity and mortality with COVID-19.It should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19.Additional, the research in the cutaneous complication of diabetes with COVID-19 need to be considered. Therefore, particular concern should be given to diabetes, and its cutaneous complications and SARS-CoV-2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445128 | PMC |
| http://dx.doi.org/10.1016/j.metop.2020.100055 | DOI Listing |
Publication Analysis
Top Keywords
diabetes cutaneous
8
covid-19 diabetes
4
cutaneous comorbidity
4
comorbidity diabetes
4
diabetes patients
4
patients higher
4
higher risk
4
risk morbidity
4
morbidity mortality
4
mortality covid-19it
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!